Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer

Altogether, our findings suggest that NACT promotes TLS formation and maturation in HGSOC lesions, de facto preserving an intratumoral ICI-sensitive T-cell phenotype. These observations emphasize the role of rational design, especially relative to the administration schedule, for clinical trials testing chemotherapy plus ICIs in patients with HGSOC. See related commentary by Bravo Melgar and Laoui, p. 10.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-08-20
DOI
https://doi.org/10.1158/1078-0432.ccr-24-1594
Citations
19
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
4.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer

Lenka Kašíková, Radek Špíšek, Kateřina Mojžíšová, Ann Vankerckhoven et al.
19 citations
Clinical Cancer Research
Immune Cell Function and Interaction
4.57
article

Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer

Lenka Kašíková, Radek Špíšek, Kateřina Mojžíšová, Ann Vankerckhoven, Petr Škapa, Hannah Griebler, Ján Laco, Ivan Práznovec, Tereza Láníčková, Roman Kocián, Francis Jacob, Jitka Fučíková, Marek Kovář, Lukáš Rob, Josef Pasulka, An Coosemans, Lorenzo Galluzzi, David Cibula, Sandra Oršulić, Tomáš Brtnický, Jana Drozenová, Pavel Dundr, Iain A. McNeish, Michal Hensler, Artemis Angelidou, Ales Ryska, Michal J. Halaska
article en
19 citations

Abstract

Altogether, our findings suggest that NACT promotes TLS formation and maturation in HGSOC lesions, de facto preserving an intratumoral ICI-sensitive T-cell phenotype. These observations emphasize the role of rational design, especially relative to the administration schedule, for clinical trials testing chemotherapy plus ICIs in patients with HGSOC. See related commentary by Bravo Melgar and Laoui, p. 10.

Clinical Cancer ResearchVol. 31(1)
Cedars-Sinai Medical Center (US), University of California, Los Angeles (US), University of Basel (CH), Czech Academy of Sciences (CZ), Cornell University (US), Charles University (CZ), Rega Institute for Medical Research (BE), University Hospital of Basel (CH), Lander Institute (IL), Generi Biotech (Czechia) (CZ), VIB-KU Leuven Center for Cancer Biology (BE), Ovarian Cancer Action (GB), University Hospital in Motol (CZ), Institute of Microbiology (BY), CancerCare (US), Sotio (Czechia) (CZ), Czech Academy of Sciences, Institute of Microbiology (CZ), Department of Biomedicine Basel (CH), University Hospital Hradec Králové (CZ), University Hospital Kralovske Vinohrady (CZ), VA Greater Los Angeles Healthcare System (US), General University Hospital in Prague (CZ), Imperial College London (GB), KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 5%
Immune Cell Function and Interaction
4.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.